Science 37 Reports Third Quarter 2022 Financial Results
10 nov. 2022 16h01 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
01 nov. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022...
Science 37 appoints Paul von Autenried to its Board of Directors
05 oct. 2022 16h15 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the appointment of seasoned...
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
12 sept. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced that Michael Shipton has been...
Science 37 to Present at the Baird 2022 Global Healthcare Conference
08 sept. 2022 16h01 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be...
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
07 sept. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a partnership with...
New Science 37 Technology Accelerates Patient Recruitment and Enrollment
24 août 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) today announced new patient relationship management and contact center technology to improve...
Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials
18 août 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading...
Science 37 Reports Second Quarter 2022 Financial Results
11 août 2022 06h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022
28 juil. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 28, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report second quarter...